As of December 31, 2023, Observe Medical ASA carries a market capitalization of 62.26M, placing it among publicly traded companies globally. Its enterprise value stands at 104.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 62.26M |
| Enterprise Value | 104.53M |
As of December 31, 2023, Observe Medical ASA has 22.91M shares outstanding.
| Shares Outstanding | 22.91M |
These figures are as of December 31, 2023.
| PB Ratio | 1.52 |
| P/TBV Ratio | -0.60 |
As of December 31, 2023, Observe Medical ASA maintains a current ratio of 0.45, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.45 |
| Quick Ratio | 0.22 |
| Debt / Equity | 136.89 |
These figures cover the twelve months ended December 31, 2023.
| Employee Count | 15.00 |
Over the twelve months ended December 31, 2023, Observe Medical ASA recorded 42,000.00 in income tax expense.
| Income Tax | 42,000.00 |
As of the close on October 22, 2026, Observe Medical ASA's stock has gained approximately 25.76% over the past 52 weeks. The 50-day moving average sits at 0.94, while the 200-day moving average is 0.98.
| 52-Week Price Change | 25.76% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 0.98 |
As of December 31, 2023, Observe Medical ASA holds 13.68M in cash and equivalents against 55.95M in total debt, resulting in a net debt position of 41.61M. Total book value stands at 40.87M, with working capital of -33.63M providing operational flexibility.
| Cash & Cash Equivalents | 13.68M |
| Total Debt | 55.95M |
| Net Debt | 41.61M |
| Equity (Book Value) | 40.87M |
| Book Value Per Share | 1.78 |
| Working Capital | -33.63M |
These figures cover the twelve months ended December 31, 2023.
| Capital Expenditures | -4.73M |
Observe Medical ASA's most recent stock split took place on June 12, 2025 with a 113:193 split ratio.
| Last Split Date | 6/12/2025 |
| Split Ratio | 113:193 |
Already premium?